108 related articles for article (PubMed ID: 27574735)
1. Exenatide Regulates Substrate Preferences Through the p38γ MAPK Pathway After Ischaemia/Reperfusion Injury in a Rat Heart.
Zheng A; Cao L; Qin S; Chen Y; Li Y; Zhang D
Heart Lung Circ; 2017 Apr; 26(4):404-412. PubMed ID: 27574735
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
3. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
[TBL] [Abstract][Full Text] [Related]
4. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
[TBL] [Abstract][Full Text] [Related]
5. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway.
Li C; He J; Gao Y; Xing Y; Hou J; Tian J
Cardiovasc Toxicol; 2014 Jun; 14(2):145-52. PubMed ID: 24297260
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Signatures of the Exenatide Nanoparticles Complex Against Myocardial Ischemia Reperfusion Injury.
Zhang Y; Qian P; Zhou H; Shen R; Hu B; Shen Y; Zhang X; Shen X; Xu G; Jin L
Kidney Blood Press Res; 2018; 43(4):1273-1284. PubMed ID: 30078011
[TBL] [Abstract][Full Text] [Related]
8. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
Li G; Qian W; Zhao C
Can J Physiol Pharmacol; 2016 Jan; 94(1):97-103. PubMed ID: 26550918
[TBL] [Abstract][Full Text] [Related]
9. Exenatide Prevents Morphological and Structural Changes of Mitochondria Following Ischaemia-Reperfusion Injury.
Lee KH; Ha SJ; Woo JS; Lee GJ; Lee SR; Kim JW; Park HK; Kim W
Heart Lung Circ; 2017 May; 26(5):519-523. PubMed ID: 27743854
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of extendin‑4 on hypoxia/reoxygenation‑induced injury in H9c2 cells.
Lu K; Chang G; Ye L; Zhang P; Li Y; Zhang D
Mol Med Rep; 2015 Aug; 12(2):3007-16. PubMed ID: 25936390
[TBL] [Abstract][Full Text] [Related]
11. p38
Wu HY; Mao XF; Fan H; Wang YX
Mol Pharmacol; 2017 May; 91(5):451-463. PubMed ID: 28202578
[TBL] [Abstract][Full Text] [Related]
12. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J
Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196
[TBL] [Abstract][Full Text] [Related]
13. Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency.
Bao W; Aravindhan K; Alsaid H; Chendrimada T; Szapacs M; Citerone DR; Harpel MR; Willette RN; Lepore JJ; Jucker BM
PLoS One; 2011; 6(8):e23570. PubMed ID: 21887274
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
Omar MA; Wang L; Clanachan AS
Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658
[TBL] [Abstract][Full Text] [Related]
15. Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart.
Brown SB; Libonati JR; Selak MA; Shannon RP; Simmons RA
Cardiovasc Drugs Ther; 2010 Jun; 24(3):197-205. PubMed ID: 20582459
[TBL] [Abstract][Full Text] [Related]
16. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
Timmers L; Henriques JP; de Kleijn DP; Devries JH; Kemperman H; Steendijk P; Verlaan CW; Kerver M; Piek JJ; Doevendans PA; Pasterkamp G; Hoefer IE
J Am Coll Cardiol; 2009 Feb; 53(6):501-10. PubMed ID: 19195607
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of exenatide against oxidative stress-induced injury.
Chang G; Zhang D; Yu H; Zhang P; Wang Y; Zheng A; Qin S
Int J Mol Med; 2013 Nov; 32(5):1011-20. PubMed ID: 23982489
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition.
Lim NR; Thomas CJ; Silva LS; Yeap YY; Yap S; Bell JR; Delbridge LM; Bogoyevitch MA; Woodman OL; Williams SJ; May CN; Ng DC
Biochem J; 2013 Dec; 456(2):149-61. PubMed ID: 24032640
[TBL] [Abstract][Full Text] [Related]
19. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling.
Luiken JJ; Momken I; Habets DD; El Hasnaoui M; Coumans WA; Koonen DP; Glatz JF; Bonen A
Endocrinology; 2006 Nov; 147(11):5205-16. PubMed ID: 17038550
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway.
Chang G; Liu J; Qin S; Jiang Y; Zhang P; Yu H; Lu K; Zhang N; Cao L; Wang Y; Li Y; Zhang D
Int J Mol Med; 2018 Mar; 41(3):1693-1703. PubMed ID: 29286061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
